Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 22 | 2022 | 369 | 8.050 |
Why?
|
| Psychotic Disorders | 6 | 2022 | 147 | 3.120 |
Why?
|
| Antipsychotic Agents | 9 | 2022 | 414 | 3.060 |
Why?
|
| Clozapine | 2 | 2022 | 24 | 1.680 |
Why?
|
| Suicide, Attempted | 6 | 2022 | 129 | 1.640 |
Why?
|
| Marijuana Abuse | 3 | 2019 | 67 | 1.300 |
Why?
|
| Toxoplasmosis | 4 | 2016 | 28 | 1.200 |
Why?
|
| Kynurenine | 2 | 2016 | 71 | 1.090 |
Why?
|
| Schizophrenic Psychology | 6 | 2018 | 102 | 1.050 |
Why?
|
| Gliadin | 2 | 2016 | 6 | 1.040 |
Why?
|
| Bipolar Disorder | 6 | 2019 | 376 | 1.020 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 2 | 2021 | 13 | 0.850 |
Why?
|
| Veterans | 2 | 2022 | 1641 | 0.760 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 527 | 0.640 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 341 | 0.610 |
Why?
|
| L-Selectin | 1 | 2017 | 34 | 0.600 |
Why?
|
| Interleukin-6 | 1 | 2021 | 1038 | 0.580 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 39 | 0.580 |
Why?
|
| Tryptophan | 1 | 2016 | 127 | 0.560 |
Why?
|
| Triglycerides | 1 | 2019 | 603 | 0.560 |
Why?
|
| Dyslipidemias | 1 | 2019 | 235 | 0.550 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 231 | 0.540 |
Why?
|
| Overweight | 1 | 2019 | 484 | 0.520 |
Why?
|
| Toxoplasma | 2 | 2012 | 14 | 0.520 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 1021 | 0.510 |
Why?
|
| Affective Symptoms | 1 | 2015 | 102 | 0.500 |
Why?
|
| Mood Disorders | 2 | 2018 | 163 | 0.490 |
Why?
|
| Length of Stay | 3 | 2019 | 1900 | 0.490 |
Why?
|
| GTP Cyclohydrolase | 1 | 2014 | 7 | 0.490 |
Why?
|
| Body Mass Index | 2 | 2019 | 2203 | 0.480 |
Why?
|
| Phenylalanine | 1 | 2014 | 142 | 0.470 |
Why?
|
| Hospitals, Psychiatric | 3 | 2018 | 82 | 0.450 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 333 | 0.440 |
Why?
|
| Antibodies, Protozoan | 1 | 2011 | 87 | 0.400 |
Why?
|
| Cognition | 2 | 2017 | 968 | 0.380 |
Why?
|
| Coronavirus | 1 | 2010 | 40 | 0.370 |
Why?
|
| Medication Adherence | 1 | 2015 | 492 | 0.370 |
Why?
|
| Influenza B virus | 1 | 2010 | 127 | 0.370 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 259 | 0.370 |
Why?
|
| Influenza A virus | 1 | 2010 | 270 | 0.340 |
Why?
|
| Autoantibodies | 1 | 2013 | 576 | 0.340 |
Why?
|
| Inflammation | 1 | 2019 | 2522 | 0.330 |
Why?
|
| Adult | 20 | 2021 | 77950 | 0.330 |
Why?
|
| Male | 26 | 2021 | 123000 | 0.320 |
Why?
|
| Cognition Disorders | 2 | 2014 | 786 | 0.310 |
Why?
|
| Female | 26 | 2021 | 141928 | 0.300 |
Why?
|
| Smoking | 2 | 2013 | 2440 | 0.290 |
Why?
|
| Middle Aged | 18 | 2021 | 86204 | 0.270 |
Why?
|
| Humans | 36 | 2022 | 261506 | 0.260 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 207 | 0.260 |
Why?
|
| Substance Abuse Detection | 2 | 2015 | 64 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2021 | 6100 | 0.250 |
Why?
|
| Aging | 1 | 2013 | 1582 | 0.240 |
Why?
|
| Self-Injurious Behavior | 2 | 2015 | 54 | 0.230 |
Why?
|
| Suicide | 2 | 2019 | 180 | 0.230 |
Why?
|
| Cocaine | 2 | 2015 | 233 | 0.230 |
Why?
|
| Hypertension | 1 | 2013 | 1503 | 0.230 |
Why?
|
| Influenza, Human | 1 | 2010 | 925 | 0.220 |
Why?
|
| Comorbidity | 3 | 2019 | 2352 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2010 | 651 | 0.210 |
Why?
|
| Violence | 2 | 2013 | 116 | 0.210 |
Why?
|
| Linear Models | 2 | 2016 | 1085 | 0.200 |
Why?
|
| P-Selectin | 1 | 2021 | 124 | 0.200 |
Why?
|
| Cannabinoids | 2 | 2019 | 38 | 0.200 |
Why?
|
| Odds Ratio | 3 | 2016 | 2316 | 0.190 |
Why?
|
| Young Adult | 7 | 2019 | 21445 | 0.190 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 1178 | 0.190 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 901 | 0.190 |
Why?
|
| Patient Admission | 2 | 2018 | 220 | 0.170 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 4314 | 0.170 |
Why?
|
| Safety-net Providers | 1 | 2018 | 53 | 0.160 |
Why?
|
| Depressive Disorder, Major | 2 | 2016 | 441 | 0.160 |
Why?
|
| Antipyretics | 1 | 2016 | 10 | 0.150 |
Why?
|
| Psychomotor Agitation | 1 | 2016 | 78 | 0.140 |
Why?
|
| Biomarkers | 2 | 2021 | 5047 | 0.140 |
Why?
|
| Nurses | 1 | 2016 | 80 | 0.140 |
Why?
|
| Patient Discharge | 2 | 2019 | 661 | 0.130 |
Why?
|
| Anti-Anxiety Agents | 1 | 2015 | 90 | 0.130 |
Why?
|
| Obesity | 2 | 2019 | 2884 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 2803 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 604 | 0.120 |
Why?
|
| Psychopathology | 1 | 2014 | 33 | 0.120 |
Why?
|
| Delirium | 1 | 2017 | 207 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 218 | 0.120 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 367 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 176 | 0.120 |
Why?
|
| Scotland | 1 | 2013 | 38 | 0.110 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2016 | 185 | 0.110 |
Why?
|
| Germany | 1 | 2013 | 111 | 0.110 |
Why?
|
| Psychiatry | 1 | 2016 | 307 | 0.110 |
Why?
|
| Diastole | 1 | 2013 | 187 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 435 | 0.110 |
Why?
|
| Seasonal Affective Disorder | 1 | 2012 | 1 | 0.110 |
Why?
|
| Tyrosine | 1 | 2014 | 498 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 336 | 0.100 |
Why?
|
| United States | 2 | 2021 | 15433 | 0.100 |
Why?
|
| Phototherapy | 1 | 2012 | 75 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 1323 | 0.100 |
Why?
|
| Reading | 1 | 2012 | 81 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2014 | 478 | 0.100 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 190 | 0.100 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 598 | 0.090 |
Why?
|
| Seasons | 1 | 2012 | 340 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1148 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 918 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 395 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2014 | 785 | 0.090 |
Why?
|
| Cholesterol | 1 | 2013 | 658 | 0.090 |
Why?
|
| Adolescent | 4 | 2014 | 31252 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 1209 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2021 | 6869 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 882 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1129 | 0.080 |
Why?
|
| Brain | 2 | 2021 | 4113 | 0.080 |
Why?
|
| Aged | 4 | 2021 | 70117 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2013 | 1467 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2010 | 557 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2013 | 2450 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2016 | 1375 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 4298 | 0.060 |
Why?
|
| Risk Factors | 4 | 2016 | 17523 | 0.060 |
Why?
|
| Logistic Models | 1 | 2010 | 3441 | 0.060 |
Why?
|
| Age Factors | 1 | 2013 | 5377 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 4320 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2014 | 445 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2019 | 37905 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2021 | 436 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2014 | 2307 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2013 | 12873 | 0.040 |
Why?
|
| Psychiatric Nursing | 1 | 2016 | 6 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 59536 | 0.040 |
Why?
|
| Malondialdehyde | 1 | 2014 | 47 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 61 | 0.030 |
Why?
|
| Catalase | 1 | 2014 | 70 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 672 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2015 | 170 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 266 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 1351 | 0.030 |
Why?
|
| Inpatients | 1 | 2019 | 678 | 0.030 |
Why?
|
| Eye Movements | 1 | 2012 | 116 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 1489 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2016 | 1171 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 330 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 980 | 0.020 |
Why?
|
| Hospitalization | 1 | 2018 | 2083 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 3260 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 2594 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4744 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1819 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2012 | 862 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 1509 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7573 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 5687 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 32848 | 0.010 |
Why?
|